Showing Results for
- Academic Journals (17)
Search Results
- 17
Academic Journals
- 17
- Search Terms:
- 1From: Thrombosis Journal. (Vol. 5) Peer-ReviewedAuthors: Sonal Vora [1]; Kanjaksha Ghosh (corresponding author) [1]; Shrimati Shetty [1]; Vinita Salvi [2]; Purnima Satoskar [3] Background The incidence of venous thrombosis in pregnant women is approximately 1 in...
- 2From: Thrombosis Journal. (Vol. 5) Peer-ReviewedAuthors: Gary W Moore (corresponding author) [1] Background Lupus anticoagulants (LA) comprise part of the heterogeneous spectrum of acquired autoantibodies termed antiphospholipid antibodies (APA) [1]. The...
- 3From: Thrombosis Journal. (Vol. 5) Peer-ReviewedAbstract Recommendations for urgent reversal of oral anticoagulation with vitamin [K.sub.1] antagonists are largely derived from case series employing empirical dosing regimens with vitamin [K.sub.1] and prothrombin...
- 4From: Thrombosis Journal. (Vol. 5) Peer-ReviewedAuthors: Christoph Sucker [1]; Kai Zacharowski [2]; Matthias Thielmann [3]; Matthias Hartmann (corresponding author) [4] Background Gram-negative sepsis is mediated by lipopolysaccharide (LPS), a bacterial membrane...
- 5From: Thrombosis Journal. (Vol. 5) Peer-ReviewedAuthors: Jawed Fareed (corresponding author) [1]; Jeanine M Walenga [1] The low molecular weight heparins (LMWHs) represent a group of antithrombotic and anticoagulant drugs which were initially developed for the...
- 6From: Thrombosis Journal. (Vol. 5) Peer-ReviewedAuthors: Massimo Franchini (corresponding author) [1]; Franco Capra [2]; Giovanni Targher [3]; Martina Montagnana [4]; Giuseppe Lippi [4] Review Introduction Von Willebrand factor (VWF) is a large adhesive...
- 7From: Thrombosis Journal. (Vol. 5) Peer-ReviewedAuthors: Ivy Altomare (corresponding author) [1]; Alan Adler [1]; Louis M Aledort [1] Background There is growing evidence that thrombophilia defects can impact pregnancy outcomes. It is already well-known that the...
- 8From: Thrombosis Journal. (Vol. 5) Peer-ReviewedAuthors: Matthijs van Wissen (corresponding author) [1,2]; Tymen T Keller [1]; Brechje Ronkes [1]; Victor EA Gerdes [1,2]; Hans L Zaaijer [3]; Eric CM van Gorp [2]; Dees PM Brandjes [2]; Marcel Levi [1]; Harry R Büller...
- 9From: Thrombosis Journal. (Vol. 5) Peer-ReviewedAuthors: Juan Benezet-Mazuecos [1]; Borja Ibanez [1]; Juan J Badimon (corresponding author) [1] In 1977, a major breakthrough in cardiovascular medicine was introduced by Dr. Andreas Gruentzig. In September of that...
- 10From: Thrombosis Journal. (Vol. 5) Peer-ReviewedAuthors: Aung Myat (corresponding author) [1]; Arif Ahsan [2] Background Pulmonary embolism (PE) is a common but under-diagnosed disease process with an estimated incidence of about 60-70 per 100 000 of the general...
- 11From: Thrombosis Journal. (Vol. 5) Peer-ReviewedAuthors: Uzoma N Ibebuogu (corresponding author) [1]; John W Thornton [1]; Guy L Reed [1] Background Peripartum cardiomyopathy (PPCM) is a rare form of heart failure of unknown cause with a reported incidence of 1...
- 12From: Thrombosis Journal. (Vol. 5) Peer-ReviewedAuthors: Feliciano A Serrano [1]; Mohamed El-Shahawy [2]; Richard J Solomon [1]; Burton E Sobel [1]; David J Schneider (corresponding author) [1] Background Cardiovascular disease is the major cause of death in...
- 13From: Thrombosis Journal. (Vol. 5) Peer-ReviewedAuthors: Jibu J Joseph (corresponding author) [1]; Anand Pillai [2]; Diane Bramley [3] Background Clopidogrel bisulfate (Plavix® ) is an antiplatelet agent that is used in the secondary prevention of ischaemic events...
- 14From: Thrombosis Journal. (Vol. 5) Peer-ReviewedAuthors: Maristella D'Uva [1]; Pierpaolo Di Micco (corresponding author) [2]; Ida Strina [1]; Carlo Alviggi [1]; Mariateresa Iannuzzo [2]; Antonio Ranieri [1]; Antonio Mollo [1]; Giuseppe De Placido [1] Background...
- 15From: Thrombosis Journal. (Vol. 5) Peer-ReviewedAuthors: Raul Altman (corresponding author) [1,2] Background The hemostatic system is a physiological process to prevent hemorrhage and maintain a balance between clot formation and fluidity of blood in the...
- 16From: Thrombosis Journal. (Vol. 5) Peer-ReviewedAim To prospectively determine the role of platelet glycoprotein IIIa (GP IIIa) gene PlA1/PlA2 polymorphism on the long-term clinical outcome in patients with coronary artery disease undergoing coronary stenting....
- 17From: Thrombosis Journal. (Vol. 5) Peer-ReviewedBackground Gender-related differences in incidence of arterial thrombosis have been a focus of interest for years. The platelet integrin [alpha]IIb[beta]3 is primarily responsible for the interaction between...